Input combination allowances for non infringing pharmaceutical manufacturing permit country and exporter specific higher input wastage subject to prescribed documentation. The policy permits exporters manufacturing pharmaceuticals via a Non Infringing process to obtain input combinations and higher input allowances than SION or adhoc norms, subject to prescribed conditions and documentary verification. Implementation requires Notification/Public Notice changes, use of ANF 4J, a Chartered Engineer certificate (Appendix 32C), a new Appendix 23A format and a Central Excise certificate for actual consumption; approvals are country specific and exporter specific.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Input combination allowances for non infringing pharmaceutical manufacturing permit country and exporter specific higher input wastage subject to prescribed documentation.
The policy permits exporters manufacturing pharmaceuticals via a Non Infringing process to obtain input combinations and higher input allowances than SION or adhoc norms, subject to prescribed conditions and documentary verification. Implementation requires Notification/Public Notice changes, use of ANF 4J, a Chartered Engineer certificate (Appendix 32C), a new Appendix 23A format and a Central Excise certificate for actual consumption; approvals are country specific and exporter specific.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.